Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TripSitter Clinic Ltd C.KETA

Alternate Symbol(s):  TSTTF

TripSitter Clinic Ltd. is a Canada-based company. The Company has no active business.

CSE:KETA - Post Discussion

TripSitter Clinic Ltd > $KETA has great day on CSE
View:
Post by StockHawk1 on Jan 17, 2022 6:18pm

$KETA has great day on CSE

TripSitter/$KETA.C shot up almost 13% today on the CSE


$KETA connects licensed medical practitioners to potential patients to provide them with much needed ketamine therapy. 


Through $KETA's webapp, patients submit their info to see if they prequalify for ketamine therapy and after an online consultation with a practitioner, low-dose ketamine treatments are mailed right to their door.  


$KETA saves doctors money and allows for access to ketamine for patients living in remote or rurual areas. 


https://assets.website-files.com/612dbca13b24df5fda6c48e5/61a67a6faa4269231b3bec78_TripSitter-Clinic-Company-Deck.pdf


$KETA @ $0.39, MC

 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities